Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Durvalumab (D) Tremelimumab (T) Plus Chemotherapy (CT) in 1L Metastatic NSCLC: Outcomes by Tumour PD-L1 Expression in POSEIDON

E. B. Garon,B. C. Cho,A. Luft,J. Alatorre-Alexander,S. L. Geater,S. -W. Kim,G. Ursol,M. Hussein,F. L. Lim,C. -T. Yang,L. H. Araujo, H. Saito,N. Reinmuth,M. Kohlmann,X. Shi,H. Mann,S. Peters,T. Mok,M. L. Johnson

JOURNAL OF THORACIC ONCOLOGY（2022）

Cited 0|Views15
No score
Key words
Durvalumab,Tremelimumab,POSEIDON
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined